SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-032074
Filing Date
2022-11-14
Accepted
2022-11-14 16:23:15
Documents
83
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1357135
2 ex31-1.htm EX-31.1 12368
3 ex31-2.htm EX-31.2 12306
4 ex32-1.htm EX-32.1 6926
5 ex32-2.htm EX-32.2 6954
  Complete submission text file 0001493152-22-032074.txt   7207771

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vynt-20220930.xsd EX-101.SCH 55632
7 XBRL CALCULATION FILE vynt-20220930_cal.xml EX-101.CAL 104214
8 XBRL DEFINITION FILE vynt-20220930_def.xml EX-101.DEF 266844
9 XBRL LABEL FILE vynt-20220930_lab.xml EX-101.LAB 514216
10 XBRL PRESENTATION FILE vynt-20220930_pre.xml EX-101.PRE 408095
77 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1045084
Mailing Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002
Business Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002 201.528.9200
Vyant Bio, Inc. (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35817 | Film No.: 221385996
SIC: 8071 Services-Medical Laboratories